Hyundai Pharmaceutical Company Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Hyundai Pharmaceutical Company Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Hyundai Pharmaceutical Company Limited. The Company's principal activity is manufacturing of pharmaceuticals and healthcare foods and drinks. Its main medical products include Tenormin tablets, for hypertension and angina pectoris; Zestril tablets, for hypertension and congest heart failure; Elroton tablets, for coronary artery diseases; Surfolase capsules, for acute or chronic respiratory diseases resulting from respiratory obstruction and disturbance in mucous secretion; Norlevo tablets, for oral emergency contraceptives, and Divina tablets, for vasomotor symptoms associated with the menopause menorrhea. The Company also produces healthcare foods for joints and cartilage, and different kinds of healthcare drinks that are made from soybeans, red ginsengs, green teas, pumpkins and others.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report